| Brief |
Winnoz is a biotech company focused on the Internet of Medical Things (IoMT) founded in 2014. Headquarter in Taipei, and subsidiary in Israel. With 15 patents and many awards. Our vision is to be the family health steward of every customer.
With the IoMT platform from blood collection, detection and big data analysis, we enable more contribution for human health management for anyone, anywhere. We believe that preventability is the key for a better health management as a family steward to make sure that healthcare resources could be accessible to everyone and everywhere.
We first launched the WinGene genetic testing service by offering risk report with genetic testing to better assist customers in managing health and well-being. In 2019, our patented technology –Haiim, a unique blood collection device, obtained Taiwan FDA Class I Medical Device and got CE certified in 2020. Now, we collaborate with many worldwide distributors for global expansion and aim for US FDA cleared by the end of 2020.
Always here for you.
Winnoz® |
